Earth Science Tech Inc. (ETST)

[Abondanceinvest]

http://axcelonbp.com/companay/board-of-directors/
Management team & Board of directors | Axcelon Biopolymers ...
axcelonbp.com
Chandra J. Panchal, PhD. Founder, Chairman, Chief Executive Officer and Chief Scientific Officer Dr. Panchal founded Axcelon in 2001 and was a co-founder of Procyon ...
http://marsinnovation.com/portfolio/
Portfolio - MaRS Innovation
marsinnovation.com
In eight years, MaRS Innovation’s team has assessed 1,500 disclosures, created 60 companies and taken an additional 100 technologies under management. Of our ...




Linkedin ProfileChandra Panchal,Ph.D.
Chairman & CEO, Axcelon Biopolymers Corp.
Région de Montréal, Canada Biotechnologie
Entreprise actuelle
Axcelon Biopolymers Corp, Panford Investment Corp. and Axcelon Biopolymers Corp., MaRS Innovation
Précédent
Ambrilia Biopharma Inc, Procyon Biopharma Inc., John Labatt Ltd.
Enseignement
Western University

Professional Senior Executive, serial Entrepreneur, academically associated with over 28 years of experience in the biotechnology/pharmaceutical sector. Held several senior positions including Senior Scientist, Group Leader, Sr.Executive Vice-President, Co-founder and President/CEO and Chairman. Grew company from start-up to a successful publicly listed entity. On the Board of TSX/NASDAQ companies and MaRS Innovation. Extensive business development and international experience. A leader, visionary, innovative problem-solver who delivers on goals and objectives through spreading infective enthusiasm, confidence and self-pride amongst fellow colleagues and subordinates. A patient listener who has been involved in decision making in academia, business, social circles and politics.

Specialties: Drug development, Medical devices - diagnostics and wound healing; Industrial Microbiology. Public company governance.

Expérience
Chairman & CEO
Axcelon Biopolymers Corp
2005 – Aujourd’hui (12 ans)
Managing Director and CEO
Panford Investment Corp. and Axcelon Biopolymers Corp.
juillet 2008 – Aujourd’hui (8 ans 9 mois)
Consulting and Seed Investments in Biotechnology and Bioremediation. Wound healing and Regenerative Medicines Co. (Axcelon).
MaRS Innovation
Director
MaRS Innovation
2009 – Aujourd’hui (8 ans)
Member of Investment Committee, Audit and Finance Committee and Nomination Committee as well as a reviewer on POP Grants panel.
DISTINCT Capital Partners
Strategic Advisor
DISTINCT Capital Partners
juillet 2012 – Aujourd’hui (4 ans 9 mois)Région de Toronto, Canada
Senior Advisor
Panacea Global Corp.
avril 2012 – Aujourd’hui (5 ans)Région de Toronto, Canada
Executive Vice-President, Business Development, Licensing and IP
Ambrilia Biopharma Inc
mars 2006 – décembre 2008 (2 ans 10 mois)
Oncology and Infectious diseases. Lead several Licensing Deals
Co-Founder, CEO and CSO
Procyon Biopharma Inc.
février 1989 – février 2006 (17 ans 1 mois)
Oncology, Dermatology and HIV; Took company from start-up to TSX; acquired 3 companies and involved in M & A with European company.
Set up a prestigious Board fo Directors and SAB.
Group Leader R & D
John Labatt Ltd.
septembre 1978 – mai 1988 (9 ans 9 mois)
Yeast Genetics and Fermentation
Publications
Genetic approaches for improving brewing and other industrial strains
Proceedings of the VIIth International Biotechnology Symposium, New Delhi, India.
1984
Auteur(s) :
Chandra Panchal,Ph.D.,Gord Whitney, Inge Russell, Graham Stewart
Langues
Hindi, Gujarati, Swahili
Compétences
BiotechnologyLifesciencesTechnology TransferCommercializationClinical DevelopmentPharmaceutical IndustryOncologyBiopharmaceuticalsMedical DevicesDrug DiscoveryLicensingRegulatory AffairsBiochemistryBusiness DevelopmentCROVoir + de 35
Comment trouvez-vous cette traduction ? Excellente •Contient des erreurs
Formation
Western University
Western University
Ph.D., Chemical & Biocehemical Engineering
1975 – 1978
Activités et associations : Industrial microbiology - development of biosurfactants for oil separation in tar sands. Member, Graduate Student Society.
University of Toronto
University of Toronto
M.Sc., Microbiology (Genetics)
1974 – 1975
Activités et associations : E.coli genetics; Don at New College Residence (3 yrs) Member of Bookstore Committee
University of Toronto Mississauga
University of Toronto Mississauga
B.Sc (Hon), Microbiology
1969 – 1973
Groupes
MicroBiome / MicroBiota / MicroBiotic R&D and Partnering Forum
MicroBiome / MicroBiota / MicroBiotic R&D and Partnering Forum
Medical Device Opportunity
Medical Device Opportunity
BioNetwork – The BioPharma Industry's Most Exclusive Partnering Event
BioNetwork – The BioPharma Industry's Most Exclusive Partnering Event
Society for Industrial Microbiology and Biotechnology (SIMB)
Society for Industrial Microbiology and Biotechnology (SIMB)
Medical Devices Group
Medical Devices Group
Pharmaceutical & Biotech Licensing & Business Network
Pharmaceutical & Biotech Licensing & Business Network
Cancer Biologics
Cancer Biologics